📰 Current Outlook News
Page 2 - Current Outlook News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Current Outlook. Real-time updates on events, politics, business and more.
June 26, 2023
Switchgear Market size to grow by USD 121.2 billion from 2023 to 2030; The growing demand for power supply in remote areas will boost the global market growth - Facts & Factor
April 19, 2023
HOUSTON, April 19, 2023 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle") today reported results for the first quarter ended March 31,...
April 19, 2023
HOUSTON, April 19, 2023 -- Crown Castle Inc. today reported results for the first quarter ended March 31, 2023 and maintained its full year 2023 outlook, as reflected in the table below.... | April 19, 2023
December 2, 2022
/PRNewswire/ -- The "Growth Opportunities from Digital Retail Initiatives for New Electric Vehicles in Europe, North America, and China" report has been added...
April 7, 2022
Ensuring long-term data integrity has challenged researchers for decades. Here's a look at where data storage technology is heading next.
April 1, 2022
Today, the march toward fast, reliable, affordable, and durable storage media continues at full pace.
February 10, 2022
Construction Scaffolding Rental Current Outlook Developing Rapidly with Top Players by 2030
February 10, 2022
Construction Scaffolding Rental Current Outlook Developing Rapidly with Top Players by 2030
November 22, 2021
The average 30-year fixed mortgage rate increased to 3.22% last week following two weeks of rate drops. Here's more on current and future rate changes.
April 8, 2021
Panel title: Novavax participant: This event is open to Goldman Sachs clients. About Novavax Novavax, Inc. (Nasdaq: NVAX) is a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. The companys proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles designed to address urgent...